Digital Supportive Care Awareness & Navigation

Not Applicable

Completed

• Conditions: Supportive Care

• Registration Number: NCT03628794
• Lead Sponsor: Duke University

Brief Summary

To pilot test the feasibility, usability, and preliminary efficacy of the D-SCAN mobile application in cancer patients and caregivers at Duke.

Detailed Description

D-SCAN, a digital patient navigator service in the form of a mobile application ("app"), has been designed at Duke, with feedback from Duke Cancer Institute (DCI) patients, caregivers and clinicians (screenshots in Appendix A).3 Its purpose is to facilitate awareness of available Cancer Patient Support Program (CPSP) services at Duke, and to also help patients recognize their unmet symptom management needs by answering questions from the Edmonton Symptom Assessment Scale (ESAS). This novel electronic system helps to connect patients and their loved ones with existing resources tailored to their unique situations, ensuring that no supportive care needs go unaddressed, thus improving patients' lives and their cancer care.

This protocol aims to assess the feasibility, usability, and preliminary efficacy of the D-SCAN mobile application. The app data, along with quantitative and qualitative feedback obtained during the pilot, will inform future development and design of a subsequent efficacy trial.

Study Timeline

• Study First Submitted: 2018-08-10
• Study First Submitted QC: 2018-08-10
• Study First Posted: 2018-08-14
• Study Start: 2018-10-25
• Primary Completion: 2019-03-01
• Study Completion: 2019-03-01
• Status Verified: 2019-04
• Last Update Submitted: 2019-07-17
• Last Update Posted: 2019-07-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Patients who are at least age 18
• Patients who have the capacity to give consent
• Patients with advanced cancer who have initiated treatment at the DCI in the last 12 weeks
• Caregivers over the age of 18 caring for either enrolled or not enrolled patients with advanced cancer who have initiated treatment at the DCI in the last 12 weeks

Exclusion Criteria

• Patients who are too ill to participate (per clinician discretion)
• Patients not able to read or understand English

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Number of patients who complete the exit survey	12 weeks
Number of patients who return the phone	12 weeks
Number of enrolled patients complete at least 3 of the 12 symptom surveys over the study duration	12 weeks

Secondary Outcome Measures

Name	Time	Method
Frequency of use	12 weeks
Number of actions taken	12 weeks
Duration of use	12 weeks
Number of content views	12 weeks
Session Length	12 weeks

Trial Locations

Locations (1)

Duke University Cancer Center; 🇺🇸 Durham, North Carolina, United States